Skip to content

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00184288
Enrollment
0
Registered
2005-09-16
Start date
2004-11-30
Completion date
2010-12-31
Last updated
2011-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Keywords

Lipid, choline, metastasis, magnetic resonance spectroscopy, treatment response

Brief summary

The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order to optimize and avoid ineffective treatment of patients with brain metastases, in vivo MR spectroscopy can be an useful tool.

Interventions

None listed

Sponsors

The Royal Norwegian Ministry of Health
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of brain metastases

Exclusion criteria

* children * pregnancy

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026